Literature DB >> 17191387

CD4+ T cells cooperate with macrophages for specific elimination of MHC class II-negative cancer cells.

Alexandre Corthay1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17191387     DOI： 10.1007/978-0-387-34814-8_14

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  12 in total

1.  Comparison of immunologic outcomes of laparoscopic vs open approaches in clinical stage III colorectal cancer.

Authors:  Sang-Ah Han; Woo Yong Lee; Chi-Min Park; Seong Hyeon Yun; Ho-Kyung Chun
Journal:  Int J Colorectal Dis       Date:  2010-02-23       Impact factor: 2.571

2.  N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research.

Authors:  Tang-Dong Liao; Xiao-Ping Yang; Martin D'Ambrosio; Yanlu Zhang; Nour-Eddine Rhaleb; Oscar A Carretero
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

3.  Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.

Authors:  Stanimir Vuk-Pavlović; Peggy A Bulur; Yi Lin; Rui Qin; Carol L Szumlanski; Xinghua Zhao; Allan B Dietz
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

Review 4.  Rebuilding immunity in cancer patients.

Authors:  Stanimir Vuk-Pavlovic
Journal:  Blood Cells Mol Dis       Date:  2007-09-10       Impact factor: 3.039

Review 5.  Interactions between lymphocytes and myeloid cells regulate pro- versus anti-tumor immunity.

Authors:  David G DeNardo; Pauline Andreu; Lisa M Coussens
Journal:  Cancer Metastasis Rev       Date:  2010-06       Impact factor: 9.264

6.  Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts.

Authors:  Sergio A Quezada; Tyler R Simpson; Karl S Peggs; Taha Merghoub; Jelena Vider; Xiaozhou Fan; Ronald Blasberg; Hideo Yagita; Pawel Muranski; Paul A Antony; Nicholas P Restifo; James P Allison
Journal:  J Exp Med       Date:  2010-02-15       Impact factor: 14.307

Review 7.  Shifting the equilibrium in cancer immunoediting: from tumor tolerance to eradication.

Authors:  Sergio A Quezada; Karl S Peggs; Tyler R Simpson; James P Allison
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

8.  Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells.

Authors:  Ilseyar Akhmetzyanova; Gennadiy Zelinskyy; Simone Schimmer; Sven Brandau; Petra Altenhoff; Tim Sparwasser; Ulf Dittmer
Journal:  Cancer Immunol Immunother       Date:  2012-08-14       Impact factor: 6.968

9.  Harnessing dendritic cells for tumor antigen presentation.

Authors:  Stefan Nierkens; Edith M Janssen
Journal:  Cancers (Basel)       Date:  2011-04-26       Impact factor: 6.639

10.  A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer.

Authors:  M Ferrand; A Galy; F Boisgerault
Journal:  Gene Ther       Date:  2014-07-17       Impact factor: 5.250
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.